Tag: 多基因风险评分

  • 先天禀赋的可改变幅度有多大?体质PRS与生活方式干预的随机对照试验

    Evidence level: A

    中医说”体质禀赋于先天”,那么先天的遗传底色,到底能在多大程度上被后天的生活方式干预改写?随机对照试验给出了一个比”宿命论”和”万能论”都更精确的答案。

    正文

    “江山易改,禀性难移”——这句话在中医语境里,指向的是体质中那个似乎改不动的部分:先天禀赋。阳虚的人怕冷,痰湿的人易胖,血瘀的人易堵,中医把这部分归因于”先天之精”的底子。现代遗传学给了这个古老的直觉一个可量化的名字:多基因风险评分(Polygenic Risk Score, PRS)——把一个人身上成千上万个与某表型相关的基因位点按效应加权加总,得到一个代表”遗传易感性”的数字。那么问题来了:这个数字是”判决书”吗?生活方式干预能把它改写到什么程度?这恰恰是”先天禀赋可修正幅度”这个边界问题的核心。

    第一个关键结论来自糖尿病预防计划(DPP)系列研究——一个随访数千人、随机分到”强化生活方式 / 二甲双胍 / 安慰剂”三组的里程碑式 RCT。DPP 的遗传子研究反复追问同一个问题:携带高风险基因的人,干预效果是不是更差?答案出人意料地”否”。一项用 17 个胰岛素抵抗位点构建遗传风险评分(GRS)的研究发现,高 GRS 者基线胰岛素敏感性确实更低(β=−0.754/单位,P=0.001),但在生活方式和二甲双胍干预下,各组胰岛素敏感性的改善幅度与遗传负担无关——治疗×GRS 的交互项不显著(P=0.54),也就是说,遗传负担高的人,通过生活方式干预同样能获得胰岛素敏感性的改善(PMID 26525880)。这是”先天禀赋不是宿命”最直接的一条 RCT 证据。

    但”修正幅度”确实存在边界,边界恰恰藏在交互作用里。DPP 的另一项研究用 32 个脂质相关位点构建 GRS,考察其对干预后血脂的影响,结果出现了耐人寻味的”反应衰减”:在生活方式干预组,高 GRS 者 1 年后的 LDL-C 仍显著偏高(β=+0.87 mg/dl/allele,交互 P=0.02),小而密 LDL 颗粒数也更多(交互 P=0.01)——即遗传负荷越高,生活方式干预对脂质的改善效果越打折扣(PMID 22951888)。换言之:遗传不是”改不了”,而是”改的斜率”可能因人而异。这正是中医”体质调理””同病异治”的现代翻版——同样一碗补药、一套功法,落在不同遗传底子上,边际收益并不相同。

    第三条证据指向一个更反直觉的边界:光”知道”没用。 2026 年刚发表的一项 1020 人双盲 RCT 测试了”把高冠心病 PRS 告知年轻超重成人”能否驱动行为改变,结果 12 个月后 BMI、血脂、血压、药物依从性均无改善(PMID 41513891)。单纯的风险告知,不足以产生行为改变。这提示:PRS 的价值不在”宣判”,而在”分层”——它必须先转化为差异化的干预处方,才可能兑现为健康收益。

    中医自己的 RCT 也站在同一边。 一项纳入 5185 人筛出 60 名阳虚体质健康者的随机对照研究,用中药(桂附地黄丸)+生活方式干预一个月,阳虚症状评分显著下降,肠道菌群多样性与代谢组部分恢复至平和质水平,且疗效在一年随访中保持(PMID 34107861)。另一项针对吸毒戒断青年男性、按中医辨证(阳虚/阴虚/气虚/血虚)指导膳食的 RCT 同样显示,辨证饮食能显著改善相应证候要素评分(PMID 31871480)。中医”辨体论治”与”PRS 分层干预”在方法论上是同构的——都是先测出个体的”底”,再据此开不同的”方”。

    把这四条证据链拼起来,”先天禀赋可修正幅度”的答案就清晰了:遗传底色普遍可以被生活方式干预改善(DPP 铁证),但边际收益随遗传负荷与目标表型而异(脂质衰减),而且干预必须落到”处方化”而不是”告知”(PRS 沟通 RCT 阴性)。 中医体质学说的”先天禀赋”,在现代语言里就是一条条带斜率的修正曲线——不是宿命,但也不是白纸;它决定的是”改起来快慢”,而不是”能不能改”。

    证据与局限

    已验证: 高胰岛素抵抗遗传负担者在生活方式/二甲双胍干预下,胰岛素敏感性改善幅度与遗传负担无关(PMID 26525880)——遗传高风险不等于干预无效,这是 A 级 RCT 直接支撑。

    部分验证: 脂质相关遗传负荷越高,生活方式干预对 LDL-C 的改善越衰减(PMID 22951888),说明”修正幅度”存在表型特异的边界;中医阳虚体质中药+生活方式干预 RCT 有效(PMID 34107861)。

    待验证: 中国人群”九种体质 PRS × 生活方式干预”的剂量-反应 RCT(高/低 PRS 分层设计)尚未见报道;辨体 vs 一刀切干预的增量价值缺乏头对头随机证据;体质 PRS 基线水平对干预应答的效应修饰仍需跨中心验证。

    相关阅读

    证据等级: A
    参考文献: PMID 26525880, PMID 22951888, PMID 34107861, PMID 41513891, PMID 31636172


    免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

    How Far Can Innate Endowment Be Shifted? Randomized Controlled Trials of Constitution PRS and Lifestyle Interventions

    Evidence level: A

    Traditional Chinese Medicine (TCM) posits that “constitution is innate.” To what extent can this genetic baseline be rewritten by postnatal lifestyle interventions? Randomized controlled trials (RCTs) provide an answer more precise than both “fatalism” and “universalism.”

    Main Text

    “江山易改,禀性难移” (The landscape changes easily, but innate nature is hard to alter) — in the context of TCM, this points to the seemingly unchangeable component within constitution: innate constitution. Individuals with Yang deficiency fear cold; those with phlegm-dampness tend to gain weight; those with blood stasis are prone to blockages. TCM attributes this portion to the foundation of “Essence of the Heavens and Earth” (先天之精). Modern genetics has given this ancient intuition a quantifiable name: Polygenic Risk Score (PRS) — summing weighted effects across thousands of genetic loci associated with a specific phenotype to generate a number representing “genetic susceptibility.” The question arises: Is this number a “verdict”? To what extent can lifestyle interventions rewrite it? This is precisely the core of the boundary problem regarding “the modifiability of innate constitution.”

    The first key conclusion comes from the Diabetes Prevention Program (DPP) series of studies — a landmark RCT following thousands of participants randomly assigned to three groups: “intensive lifestyle / metformin / placebo.” The genetic sub-studies of DPP repeatedly asked the same question: Do individuals carrying high-risk genes show worse intervention outcomes? The answer is surprisingly “no.” A study constructing a genetic risk score (GRS) using 17 insulin resistance loci found that while high GRS individuals indeed had lower baseline insulin sensitivity ($\beta=-0.754$ per unit, $P=0.001$), the magnitude of improvement in insulin sensitivity across all groups was unrelated to genetic burden under lifestyle and metformin interventions — the interaction term (Treatment $\times$ GRS) was not significant ($P=0.54$). In other words, individuals with high genetic burden can still achieve improvements in insulin sensitivity through lifestyle interventions (PMID 26525880). This is the most direct RCT evidence supporting “innate constitution is not fate.”

    However, a “modification ceiling” does exist, hidden precisely within interaction effects. Another DPP study constructed a GRS using 32 lipid-related loci to examine its impact on intervention-induced lipid changes, revealing a perplexing “response attenuation”: in the lifestyle intervention group, high GRS individuals still had significantly elevated LDL-C one year later ($\beta=+0.87$ mg/dl/allele, interaction $P=0.02$) and higher numbers of small dense LDL particles (interaction $P=0.01$) — meaning higher genetic load results in a discounting of lifestyle intervention efficacy for lipids (PMID 22951888). In short: genetics is not “unchangeable,” but the “slope of modification” may vary by individual. This mirrors the TCM concepts of “constitution regulation” and “treating different diseases differently with the same condition” — the same tonic or set of exercises yields different marginal returns when applied to different genetic baselines.

    A third line of evidence points to a counter-intuitive boundary: mere “knowledge” is insufficient. A 2026 double-blind RCT involving 1,020 participants tested whether informing young overweight adults of their high coronary heart disease PRS could drive behavioral change. After 12 months, BMI, lipids, blood pressure, and medication adherence showed no improvement (PMID 41513891). Simple risk notification is insufficient to produce behavioral change. This suggests: The value of PRS lies not in “sentencing,” but in “stratification” — it must first be translated into differentiated intervention prescriptions before health benefits can be realized.

    RCTs within TCM itself stand on the same side. A randomized controlled study screening 5,185 individuals for 60 healthy subjects with Yang deficiency constitution found that a one-month intervention combining Chinese herbal medicine (Gui Fu Di Huang Wan) and lifestyle changes significantly reduced Yang deficiency symptom scores, restored gut microbiome diversity and parts of the metabolome to healthy constitution levels, and maintained efficacy over a one-year follow-up (PMID 34107861). Another RCT targeting young male drug addicts, guiding diets according to TCM syndromic differentiation (Yang/Yin/Qi/Blood deficiency), similarly showed that syndromic dieting significantly improved corresponding syndrome element scores (PMID 31871480). TCM’s “syndrome-based treatment” and “PRS stratified intervention” are methodologically isomorphic — both involve first measuring the individual’s “baseline,” then prescribing a different “formula” accordingly.

    Assembling these four evidence chains clarifies the answer to “the modifiability of innate constitution”: The genetic baseline is generally improvable via lifestyle interventions (DPP ironclad evidence), but marginal returns vary with genetic load and target phenotype (lipid attenuation), and interventions must be “prescription-based” rather than merely “informative” (PRS communication RCT negative results). In modern language, TCM’s theory of “innate constitution” is a series of correction curves with slopes — not fate, nor a blank slate; it determines the “speed of modification,” not whether modification is possible.

    Evidence and Limitations

    Verified: Individuals with high genetic burden for insulin resistance show no difference in the magnitude of insulin sensitivity improvement under lifestyle/metformin intervention (PMID 26525880) — high genetic risk does not equal ineffective intervention, directly supported by Level A RCT.

    Partially Verified: Higher lipid-related genetic load leads to greater attenuation of lifestyle intervention efficacy for LDL-C (PMID 22951888), indicating a phenotype-specific boundary for “modification ceiling”; TCM Yang deficiency constitution herbal medicine + lifestyle intervention RCT was effective (PMID 34107861).

    To be Verified: No reported dose-response RCT for “Nine Constitutions PRS $\times$ Lifestyle Intervention” in Chinese populations (high/low PRS stratified design); lack of head-to-head randomized evidence on the incremental value of syndrome-based vs. one-size-fits-all interventions; need for multi-center validation on effect modification by baseline constitution PRS levels on intervention response.

    Related Reading

    Evidence Level: A
    References: PMID 26525880, PMID 22951888, PMID 34107861, PMID 41513891, PMID 31636172


    Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

  • 体质多基因风险评分:从先天禀赋到可量化的因果链

    Evidence level: A

    中医所说的”先天禀赋”,在现代遗传流行病学中可以被多基因风险评分(PRS)精确量化——而且从基因→体质→疾病的因果链,正被纵向队列与孟德尔随机化方法逐步打通。

    正文

    中医体质学说有个核心主张:人的体质差异一部分”禀受于先天”,出生时就已经写进身体里,决定你容易得什么病、对什么环境敏感。过去这句话只能停留在经验层面——”先天禀赋”看不见摸不着,更像玄学。但过去十年遗传流行病学的发展,恰恰给这个古老概念配上了量化的尺子:多基因风险评分(PRS)。

    PRS 的思路很直白:复杂疾病不是单个基因决定的,而是成百上千个微小效应的基因变异累加的结果。把一个人携带的所有风险等位基因按效应大小加权求和,得到一个分数,就是这个人的”基因彩票”数字。芬兰 FinnGen 队列 13.5 万人的研究给出了这个数字的威力:与平均 PRS 相比,高 PRS 人群的终身疾病风险高出 21%–38%,冠心病、糖尿病、房颤等五种常见病的发病年龄平均提前 4–9 年(PMID 32273609)。换句话说,”先天禀赋”在多大程度上影响你什么时候得病,现在可以直接算出数字。

    这个逻辑放到中医体质上,会产生一个更深的发现。台湾生物库 11,030 人的一项研究,把抑郁症的多基因风险评分(MDD PRS)与中医体质分类(BCQ 量表)放在同一个模型里检验(PMID 39257026)。结果有三个层次:第一,MDD PRS 每升高一个标准差,阳虚体质(OR 1.07)、阴虚体质(OR 1.07)、血瘀体质(OR 1.06)的几率都显著上升——基因风险高的个体,确实更倾向于呈现”偏颇体质”;第二,阳虚体质(OR 2.07)和血瘀体质(OR 1.65)本身显著增加抑郁症风险;第三,也是最关键的一步——中介分析显示,MDD 多基因风险对抑郁症发病的效应,有 10.21% 经由阳虚体质传导、8.41% 经由血瘀体质传导。这是”基因→体质→疾病”因果链的直接统计证据:体质不只是疾病的相关标记,它可能是基因风险向疾病转化路径上的一个真实中间节点。

    那么”体质是不是病因”这个问题,还能再进一步吗?这里需要引入孟德尔随机化(MR)。MR 利用一个天然实验:基因变异在受精时随机分配,不受后天环境、生活习惯、社会经济地位等混杂因素影响。把基因变异当作”工具变量”,就可以在观察数据里模拟随机对照试验,推断暴露与结局的因果关系,而不只是相关关系。中医体质能否作为 MR 中的暴露或中介变量,取决于一个前提——体质必须能被可靠地、量化地测量。2026 年一项 1,472 人的研究展示了这条路的可行性:研究者用验证性因子分析和项目反应理论把中医”证候负荷”构造成连续潜变量,再套用 target trial emulation(目标试验模拟)+ 双重机器学习框架做因果推断,发现证候负荷每升高一个标准差,甘油三酯 z 分数上升 0.18、LDL-C 上升 0.11、C反应蛋白上升 0.16,负对照结果为零,E值 1.54–1.92 表明结果对未测混杂具有中等稳健性(PMID 42519806)。这是中医证候量化第一次完整走进现代因果推断的方法学框架。

    把三层证据拼起来,一条清晰的链路浮现:体质是可遗传的中间表型(GWAS 已定位相关位点)→ PRS 可以把”先天禀赋”变成可计算的连续分数 → 纵向队列和中介分析显示体质确实是基因风险传导的通路 → 孟德尔随机化与目标试验模拟提供了把”体质→疾病”从相关升级为因果的严格工具。对”先天禀赋”这个说法而言,这意味着一场身份转变:它从一句只能信的经验判断,变成一个可以检验、可以分层、甚至可以干预的临床工具。无锡队列 5,024 人 14 年随访给出了干预的可行性证据:高 PRS 人群如果把生活方式从糟糕(0–2 项健康因素)改进到理想(4–6 项),2 型糖尿病 10 年发病率从 6.77% 降到 3.28%(PMID 37432247)——基因风险高不是判决,而是提醒。

    证据与局限

    已验证: 体质(阳虚/阴虚/血瘀)与 MDD 多基因风险显著相关,且 MDD PRS→MDD 的效应部分由阳虚(10.21%)、血瘀(8.41%)体质中介(PMID 39257026);高 PRS 使常见病发病提前 4–9 年(PMID 32273609);中医证候负荷可量化并进入 target trial emulation 因果框架,与血脂/CRP 显著关联(PMID 42519806)。

    部分验证: “体质→疾病”的孟德尔随机化研究仍稀缺——多数 MR 用于中医药疗效与肠道菌群,直接以体质为暴露的 MR 设计尚待开展;台湾研究为横断面中介,因果时序需纵向数据确认。

    待验证: ①体质量表能否像 PRS 一样构建”体质多基因评分”并在独立队列复现;②以体质为暴露的孟德尔随机化设计(用 GWAS 定位的体质相关位点作工具变量);③体质 PRS×生活方式干预的随机对照试验,检验”先天禀赋可被后天修正”的幅度边界。

    相关阅读

    证据等级: A
    参考文献: PMID 39257026, PMID 37432247, PMID 32273609, PMID 42519806


    免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

    Polygenic Risk Scores: From Innate Endowment to Quantifiable Causal Chains

    Evidence level: A

    In Traditional Chinese Medicine (TCM), “inherent endowment” refers to the constitution determined at birth. In modern genetic epidemiology, this can be precisely quantified via Polygenic Risk Scores (PRS)—and longitudinal cohorts combined with Mendelian Randomization are progressively establishing the causal chain from genes → constitution → disease.

    Main Text

    A core tenet of TCM constitution theory is that individual differences in constitution are partly “inherently endowed,” encoded at birth and determining susceptibility to specific diseases and sensitivity to environmental factors. Historically, this concept remained empirical—”inherent endowment” was intangible and often perceived as akin to metaphysics. However, the development of genetic epidemiology over the past decade has provided a quantitative metric for this ancient concept: the Polygenic Risk Score (PRS).

    The logic of PRS is straightforward: complex diseases are not determined by a single gene but result from the cumulative effect of hundreds or thousands of minor genetic variants. By summing weighted risk alleles carried by an individual based on their effect sizes, one obtains a score representing that person’s “genetic lottery.” A study of 135,000 individuals in the Finnish FinnGen cohort demonstrated the power of this metric: compared to average PRS, high-PRS populations exhibited a 21%–38% higher lifetime disease risk and an average onset age advancement of 4–9 years for five common conditions, including coronary heart disease, diabetes, and atrial fibrillation (PMID 32273609). In other words, the extent to which “inherent endowment” influences disease onset timing can now be calculated directly.

    Applying this logic to TCM constitution yields a deeper insight. A study involving 11,030 individuals from the Taiwan BioBank integrated MDD PRS with TCM constitution classification (BCQ scale) within a unified model (PMID 39257026). The results revealed three levels of evidence: First, for every standard deviation increase in MDD PRS, the likelihood of Yang Deficiency constitution (OR 1.07), Yin Deficiency constitution (OR 1.07), and Blood Stasis constitution (OR 1.06) increased significantly—individuals with higher genetic risk indeed tended to manifest “imbalanced constitutions.” Second, Yang Deficiency (OR 2.07) and Blood Stasis (OR 1.65) constitutions themselves significantly increased the risk of depression. Third, and most critically, mediation analysis indicated that 10.21% of the effect of MDD PRS on depression onset was mediated through Yang Deficiency constitution and 8.41% through Blood Stasis constitution. This provides direct statistical evidence for the “genes → constitution → disease” causal chain: constitution is not merely a correlate of disease but may represent a genuine intermediate node in the pathway from genetic risk to clinical manifestation.

    Can the question “Is constitution a cause?” be further explored? Here, Mendelian Randomization (MR) must be introduced. MR utilizes a natural experiment: genetic variants are randomly allocated at fertilization, independent of postnatal environmental factors, lifestyle habits, or socioeconomic status. By treating genetic variants as “instrumental variables,” one can simulate randomized controlled trials within observational data to infer causal relationships between exposure and outcome rather than mere correlation. Whether TCM constitution can serve as an exposure or mediator variable in MR depends on a prerequisite: constitution must be reliably and quantitatively measured. A 2026 study involving 1,472 individuals demonstrated the feasibility of this approach: researchers constructed a continuous latent variable for TCM “syndrome burden” using confirmatory factor analysis and item response theory, then applied a target trial emulation plus double machine learning framework for causal inference. They found that for every standard deviation increase in syndrome burden, z-scores for triglycerides rose by 0.18, LDL-C by 0.11, and C-reactive protein by 0.16; null results for negative controls indicated robustness against unmeasured confounding (E-value 1.54–1.92) (PMID 42519806). This marks the first time TCM syndrome quantification has fully entered modern causal inference methodological frameworks.

    Synthesizing these three layers of evidence reveals a clear pathway: constitution is a heritable intermediate phenotype (GWAS has identified relevant loci) → PRS transforms “inherent endowment” into a calculable continuous score → longitudinal cohorts and mediation analyses confirm constitution acts as a conduit for genetic risk → Mendelian Randomization and target trial emulation provide rigorous tools to upgrade the “constitution → disease” relationship from correlation to causation. For the concept of “inherent endowment,” this signifies a shift in identity: it transitions from an empirical judgment based on faith into a testable, stratifiable, and potentially intervention-driven clinical tool. Evidence for intervention feasibility comes from the Wuxi cohort of 5,024 individuals followed over 14 years: high-PRS populations improved their lifestyle from poor (0–2 healthy factors) to ideal (4–6 healthy factors), reducing the 10-year incidence of type 2 diabetes from 6.77% to 3.28% (PMID 37432247)—high genetic risk is not a verdict, but a warning.

    Evidence and Limitations

    Verified: Significant association between constitution (Yang/Yin/Blood Stasis) and MDD PRS, with partial mediation of the MDD PRS→MDD effect via Yang Deficiency (10.21%) and Blood Stasis (8.41%) constitutions (PMID 39257026); high PRS associated with earlier onset of common diseases by 4–9 years (PMID 32273609); TCM syndrome burden quantifiable and integrated into target trial emulation causal frameworks with significant associations to lipid profiles and CRP (PMID 42519806).

    Partially Verified: Mendelian Randomization studies specifically examining “constitution → disease” remain scarce—most MR studies focus on TCM efficacy and gut microbiota; direct MR designs using constitution as exposure are still pending; the Taiwan study was cross-sectional regarding mediation, requiring longitudinal data to confirm causal temporality.

    To Be Verified: ① Can constitution scales be used to construct a “constitution PRS” replicable in independent cohorts? ② MR designs using constitution as exposure (utilizing GWAS-identified loci as instrumental variables)? ③ Randomized controlled trials examining the interaction of constitution PRS × lifestyle interventions to determine the magnitude boundary of whether “inherent endowment” can be modified postnatally.

    Related Reading

    Evidence Level: A
    References: PMID 39257026, PMID 37432247, PMID 32273609, PMID 42519806


    Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.